CUV 6.00% $14.58 clinuvel pharmaceuticals limited

Quality healthcare stocks like Clinuvel are in this basket. CUV...

  1. 789 Posts.
    lightbulb Created with Sketch. 1014
    Quality healthcare stocks like Clinuvel are in this basket. CUV has as good a ROE as any of these and much better growth - and much more shorting which I see as a big benefit for CUV when they buy back those millions of shares as this stock is so tightly held. The takeover offer has already come for Ramsay, easy to see one come for Clinuvel which has an excellent pipeline which is not priced in at all. Large and growing cash pile and profits with an FDA, EMA, TGA approved drug would add to any business immediately.
    Australian healthcare sector set to outperform as pandemic fades out – Citi
    09 Mar 2022 09:48
    • * Australian healthcare sector will benefit from the end of the COVID-19 pandemic, Citi Research says
    • * Brokerage adds companies like Cochlear Ltd , CSL Ltd , Integral Diagnostics , Ramsay Health Care and
      ASX-listed shares of Resmed Inc will outperform in the coming year
    • * Remains "positively disposed" to biotech giant CSL, retains "buy" rating and price target of A$335

    All IMO DYOR
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.58
Change
-0.930(6.00%)
Mkt cap ! $730.1M
Open High Low Value Volume
$15.35 $15.74 $14.23 $4.173M 285.1K

Buyers (Bids)

No. Vol. Price($)
1 500 $14.56
 

Sellers (Offers)

Price($) Vol. No.
$14.58 1486 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.